Autobahn Therapeutics

Restoring hope for people affected by CNS disorders

Our mission is to improve life health for people affected by CNS disorders by driving the regenerative power of the human body

We aim to restore hope for people affected by both rare and prevalent diseases by creating the next generation of regenerative medicines for the brain. By restoring the brain to a healthier state, these therapies will address the progressive and debilitating course of these conditions, allowing people to live the futures they deserve.

Learn More About Us

Creating Next Generation Therapies for CNS Disorders

Click a point to learn more

Our Science

Our Approach

Brain-Targeting Chemistry Platform

Our brain-targeting chemistry platform creates orally administered small molecule prodrugs with tunable ratios of central vs. peripheral exposure. This approach enables us to develop molecules with bespoke distribution profiles tailored to match disease pathophysiology.

Validated Human Biology

Our portfolio is anchored by high-confidence programs that leverage established clinical precedence, human genetics and biology, de-risking our pipeline and accelerating early development.

Biomarker-Driven Development

Our programs utilize biomarker-driven development strategies to demonstrate on-target / on-tissue activity and proof-of-mechanism early in the clinic.

Our Team
We have built a world-class team with deep expertise in thyromimetics, drug discovery and development, clinical operations, corporate development and commercialization unified by a singular mission to restore hope for people affected by CNS disorders.
About Us
Join Us
We’re looking for high-performing individuals who are passionate about science and excited to work in a collaborative environment fueled by a rigorous and entrepreneurial culture.
Join Our Team
Autobahn
Autobahn
Autobahn